{"transactions":[{"id":932895,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:34.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":53400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 178,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 53,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 17,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 124,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":375203,"source":{"system":"sec-edgar","filing":"0001477932-26-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000364/form4.xml","form_type":"4"}},{"id":1009203,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-11-04T21:01:21.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4648,"price":0.434,"value":2017.232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,996 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":321803,"source":{"system":"sec-edgar","filing":"0001477932-25-007899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007899/form4.xml","form_type":"4"}},{"id":1022731,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-10-07T20:05:47.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5834,"price":0.648,"value":3780.432,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":326451,"source":{"system":"sec-edgar","filing":"0001477932-25-007405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007405/form4.xml","form_type":"4"}},{"id":1031000,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-09-30T20:02:00.000Z","date":"2025-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5230,"price":0.605,"value":3164.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 19,125 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":332285,"source":{"system":"sec-edgar","filing":"0001477932-25-007232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225007232/form4.xml","form_type":"4"}},{"id":1063244,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:06.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":33991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 33,991 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 16,996 units and 16,995 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":337515,"source":{"system":"sec-edgar","filing":"0001477932-25-006100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006100/form4.xml","form_type":"4"}},{"id":1075696,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-08-05T20:01:48.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6393,"price":0.64,"value":4091.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 23,377 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":303524,"source":{"system":"sec-edgar","filing":"0001477932-25-005474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005474/form4.xml","form_type":"4"}},{"id":1093769,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-07-03T17:05:24.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4462,"price":0.7679,"value":3426.3698,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,871 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":309917,"source":{"system":"sec-edgar","filing":"0001477932-25-004913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004913/form4.xml","form_type":"4"}},{"id":1126738,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:06.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11683,"price":0.503,"value":5876.549,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 35,783 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":314379,"source":{"system":"sec-edgar","filing":"0001477932-25-004371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004371/form4.xml","form_type":"4"}},{"id":1126737,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:06.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":23377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 23,377 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 7,793 units, 7,792 units, and 7,792 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":326062,"source":{"system":"sec-edgar","filing":"0001477932-25-004371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004371/form4.xml","form_type":"4"}},{"id":1160387,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-05-05T20:05:34.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10205,"price":0.4875,"value":4974.9375,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 31,256 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":302685,"source":{"system":"sec-edgar","filing":"0001477932-25-003317","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225003317/form4.xml","form_type":"4"}},{"id":1233963,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2025-03-04T21:01:39.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":19300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2025, the reporting person was awarded 19,300 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 6,434 units, 6,433 units, and 6,433 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":312890,"source":{"system":"sec-edgar","filing":"0001477932-25-001458","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225001458/form4.xml","form_type":"4"}},{"id":1346412,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-12-03T21:01:06.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":16871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 1, 2024, the reporting person was awarded 16,871 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,624 units, 5,624 units, and 5,623 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":293590,"source":{"system":"sec-edgar","filing":"0001477932-24-007799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007799/form4.xml","form_type":"4"}},{"id":1389756,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-10-08T20:01:57.000Z","date":"2024-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5834,"price":0.883,"value":5151.422,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":276719,"source":{"system":"sec-edgar","filing":"0001477932-24-006286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224006286/form4.xml","form_type":"4"}},{"id":1397614,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-10-01T20:05:38.000Z","date":"2024-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5230,"price":0.578,"value":3022.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 19,125 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":282553,"source":{"system":"sec-edgar","filing":"0001477932-24-006098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224006098/form4.xml","form_type":"4"}},{"id":1417079,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-09-04T20:02:22.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":35783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 1, 2024, the reporting person was awarded 35,783 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 11,928 units, 11,928 units, and 11,927 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":287783,"source":{"system":"sec-edgar","filing":"0001477932-24-005497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005497/form4.xml","form_type":"4"}},{"id":1432057,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-08-16T20:05:49.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On Sept 28, 2023, the reporting person was awarded 85,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 21,250 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 7,083 units, 7,083 units, and 7,084 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 36,125 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 27,625 RSUs did not vest and were cancelled on August 15, 2024."}],"balance_after":252000,"source":{"system":"sec-edgar","filing":"0001477932-24-005026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005026/form4.xml","form_type":"4"}},{"id":1494251,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-06-04T20:05:37.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":31256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2024, the reporting person was awarded 31,256 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 10,419 units, 10,419 units, and 10,418 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":230750,"source":{"system":"sec-edgar","filing":"0001477932-24-003480","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003480/form4.xml","form_type":"4"}},{"id":1529807,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-05-03T20:07:43.000Z","date":"2024-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15504,"price":0.87,"value":13488.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 50,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":199494,"source":{"system":"sec-edgar","filing":"0001477932-24-002515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224002515/form4.xml","form_type":"4"}},{"id":1670358,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2024-01-26T21:02:54.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":36125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 28, 2023, the reporting person was awarded 85,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 36,125 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 12,042 units, 12,042 units, and 12,041 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":214998,"source":{"system":"sec-edgar","filing":"0001477932-24-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224000405/form4.xml","form_type":"4"}},{"id":1706253,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-12-19T15:59:40.000Z","date":"2023-12-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.83,"value":8300.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":99350,"source":{"system":"sec-edgar","filing":"0001477932-23-009233","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223009233/form4.xml","form_type":"4"}},{"id":1708487,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-12-18T14:38:49.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.77,"value":7700.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":89350,"source":{"system":"sec-edgar","filing":"0001477932-23-009191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223009191/form4.xml","form_type":"4"}},{"id":1738359,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-11-17T15:01:58.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.81,"value":8100.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":79350,"source":{"system":"sec-edgar","filing":"0001477932-23-008596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223008596/form4.xml","form_type":"4"}},{"id":1764088,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-10-06T20:06:03.000Z","date":"2023-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5834,"price":0.675,"value":3937.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,334 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":178873,"source":{"system":"sec-edgar","filing":"0001477932-23-007443","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223007443/form4.xml","form_type":"4"}},{"id":1804856,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-08-17T13:40:47.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":1.21,"value":9680.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":69350,"source":{"system":"sec-edgar","filing":"0001477932-23-006234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223006234/form4.xml","form_type":"4"}},{"id":1833382,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-07-07T20:02:22.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":28800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 64,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,800 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,600 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 11,200 RSUs and 24,000 RSUs subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":184707,"source":{"system":"sec-edgar","filing":"0001477932-23-005118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223005118/form4.xml","form_type":"4"}},{"id":1865823,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-06-06T14:14:28.000Z","date":"2023-06-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.59,"value":15900.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":61350,"source":{"system":"sec-edgar","filing":"0001477932-23-004251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223004251/form4.xml","form_type":"4"}},{"id":1907403,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-05-03T20:20:23.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":14293,"price":1.67,"value":23869.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 50,000 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":155907,"source":{"system":"sec-edgar","filing":"0001477932-23-003072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223003072/form4.xml","form_type":"4"}},{"id":2055292,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2023-01-13T21:04:47.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 64,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 24,000 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 8,000 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in October 2022, the rights with respect to 11,200 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":170200,"source":{"system":"sec-edgar","filing":"0001477932-23-000277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223000277/form4.xml","form_type":"4"}},{"id":2080553,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-12-20T15:30:56.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":51350,"source":{"system":"sec-edgar","filing":"0001477932-22-009425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222009425/form4.xml","form_type":"4"}},{"id":2089029,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-12-13T14:59:36.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":4350,"price":2.09,"value":9091.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":46350,"source":{"system":"sec-edgar","filing":"0001477932-22-009249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222009249/form4.xml","form_type":"4"}},{"id":2103044,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-11-29T15:57:25.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":5000,"price":2.21,"value":11050.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares of common stock are jointly owned by the reporting person and his spouse."}],"balance_after":42000,"source":{"system":"sec-edgar","filing":"0001477932-22-008934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222008934/form4.xml","form_type":"4"}},{"id":2137426,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-10-14T20:07:08.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":11200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 64,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 11,200 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,734 units, 3,733 units, and 3,733 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":146200,"source":{"system":"sec-edgar","filing":"0001477932-22-007701","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007701/form4.xml","form_type":"4"}},{"id":2175602,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-08-24T14:52:39.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":5000,"price":1.6,"value":8000.0,"ownership":{"direct":true},"balance_after":165000,"source":{"system":"sec-edgar","filing":"0001477932-22-006435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222006435/form4.xml","form_type":"4"}},{"id":2176623,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-08-23T15:14:20.000Z","date":"2022-08-22","kind":"purchase","acquired":true,"shares":5000,"price":1.64,"value":8200.0,"ownership":{"direct":true},"balance_after":160000,"source":{"system":"sec-edgar","filing":"0001477932-22-006406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222006406/form4.xml","form_type":"4"}},{"id":2222609,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:05:49.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":34060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 34,060 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 17,030 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 18,340 shares subject to the award previously vested and remain subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 34,060 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 17,030 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 18,340 shares subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":52400,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":34060},"source":{"system":"sec-edgar","filing":"0001477932-22-004667","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004667/form4.xml","form_type":"4"}},{"id":2229236,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-06-17T20:05:26.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":10000,"price":2.05,"value":20500.0,"ownership":{"direct":true},"balance_after":155000,"source":{"system":"sec-edgar","filing":"0001477932-22-004498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004498/form4.xml","form_type":"4"}},{"id":2229235,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Common Stock","published_at":"2022-06-17T20:05:26.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":15000,"price":2.79,"value":41850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 50,000 restricted stock units.  No shares were sold by the reporting person or VolitionRx in such transaction."}],"balance_after":145000,"source":{"system":"sec-edgar","filing":"0001477932-22-004498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004498/form4.xml","form_type":"4"}},{"id":2300887,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Volition Veterinary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:03:04.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":18340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 18,340 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,170 shares on each of August 3, 2022 and August 3, 2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 18,340 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,170 shares on each of August 3, 2022 and August 3, 2023, respectively."}],"balance_after":18340,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":18340},"source":{"system":"sec-edgar","filing":"0001477932-22-002180","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002180/form4.xml","form_type":"4"}},{"id":2505939,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO-Volition Veterinary"}}],"security":"Common Stock","published_at":"2021-11-18T15:39:40.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":10000,"price":4.02,"value":40200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001477932-21-008524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221008524/form4.xml","form_type":"4"}},{"id":2731908,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO-Volition Veterinary"}}],"security":"Common Stock","published_at":"2021-05-04T20:27:43.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with his employment as Chief Executive Officer of Volition Veterinary Diagnostics Development, LLC, Dr. Butera received restricted stock units subject to a 3-year vesting schedule, vesting as to 50,000 units on each of 05/01/22, 05/01/23 and 05/01/24, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001078782-21-000416","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878221000416/primary_doc.xml","form_type":"4"}},{"id":2731907,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO-Volition Veterinary"}}],"security":"Common Stock","published_at":"2021-05-04T20:27:43.000Z","date":"2021-03-25","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved a cancellation of unvested restricted stock units upon Dr. Butera's resignation as a director of the issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001078782-21-000416","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878221000416/primary_doc.xml","form_type":"4"}},{"id":2959832,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":68969,"kind":"person","name":"Butera Salvatore Thomas","position":1,"cik":"0001834339","reported_name":"Butera Salvatore Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-03T21:42:51.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Butera received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 12/01/21 and 12/01/22, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001078782-20-000946","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000946/primary_doc.xml","form_type":"4"}}]}